| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/12/2007 | WO2007078806A2 Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine |
| 07/12/2007 | WO2007078744A2 Cholesterol measurement system and method |
| 07/12/2007 | WO2007078457A2 Compositions and methods for the detection of a nucleic acid using a cleavage reaction |
| 07/12/2007 | WO2007078315A2 Customizable and renewable nanostructured interface for bioelectronic applications |
| 07/12/2007 | WO2007078029A1 A quantitative method for hbv-dna, a primer and probe for detecting hbv-dna, and a detecting kit comprising the same |
| 07/12/2007 | WO2007077977A1 Composition and method for predicting the postoperative prognosis or metastatic risk of cancer patient |
| 07/12/2007 | WO2007077952A1 Method and device for determining a nucleic acid allele or base sequence |
| 07/12/2007 | WO2007077563A2 Solid-fluid composition |
| 07/12/2007 | WO2007077562A2 Antiseptic compositions and methods of using same |
| 07/12/2007 | WO2007077561A2 Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents |
| 07/12/2007 | WO2007077560A2 Cryoprotective compositions and methods of using same |
| 07/12/2007 | WO2007077425A2 Mutation in the growth hormone receptor |
| 07/12/2007 | WO2007077423A2 Growth hormone variations |
| 07/12/2007 | WO2007077422A2 Allele-specific sequencing |
| 07/12/2007 | WO2007077291A1 Method for determination of concentration, charge or unit size of a substance |
| 07/12/2007 | WO2007077262A1 Process for the detection of cytosine methylations |
| 07/12/2007 | WO2007076989A1 Method for the individual characterization of therapeutic target molecules and use thereof |
| 07/12/2007 | WO2007076865A1 Bioreactor for cell and tissue culture |
| 07/12/2007 | WO2007076726A1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
| 07/12/2007 | WO2007076577A1 Microarray methods |
| 07/12/2007 | WO2007061906A3 Diagnostic and therapeutics for cardiovascular disorders |
| 07/12/2007 | WO2007059103A3 Serum response factor and myocardin control alzheimer cerebral amyloid angiopathy |
| 07/12/2007 | WO2007056201A3 THERAPEUTIC AGENT FOR iNOS GENERATING ILLNESS |
| 07/12/2007 | WO2007056177A3 T315a and f317i mutations of bcr-abl kinase domain |
| 07/12/2007 | WO2007053015A3 Disease resistent cucumber plants |
| 07/12/2007 | WO2007048076A3 Method for the diagnosis and prognosis of cancer |
| 07/12/2007 | WO2007048067A3 C-kit oncogene mutations in melanoma |
| 07/12/2007 | WO2007035092A3 Vhh for the diagnosis, prevention and treatment of diseases associated with protein aggregates |
| 07/12/2007 | WO2007033834A3 Method for the analysis of nucleic acid methylation |
| 07/12/2007 | WO2007033079A3 Method of manufacturing a diagnostic test strip |
| 07/12/2007 | WO2007025097A3 Use |
| 07/12/2007 | WO2007019945A3 Method and kit for detection of components of bovine tissue in products of animal origin produced in comminuting conditions |
| 07/12/2007 | WO2007019570A3 Selective dehybridization using electrochemically-generated reagent on an electrode microarray |
| 07/12/2007 | WO2007016269A3 Detection of polyphosphate using fluorescently labeled polyphosphate acceptor substrates |
| 07/12/2007 | WO2007015178A3 Library of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 07/12/2007 | WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/12/2007 | WO2007012934A3 Methods for identifying genes that increase yeast stress tolerance, and use of these genes for yeast strain improvement |
| 07/12/2007 | WO2007011902A3 Methods for rna profiling |
| 07/12/2007 | WO2007000673A3 Feline hemoplasma isolate |
| 07/12/2007 | WO2006138377A3 Compound combinations for inhibiting cell division and methods for their identification and use |
| 07/12/2007 | WO2006119434A3 DNA METHYLATION MARKERS ASSOCIATED WITH THE CpG ISLAND METHYLATOR PHENOTYPE (CIMP) IN HUMAN COLORECTAL CANCER |
| 07/12/2007 | WO2006118988A3 Cellular biomarker antioxidant assay and uses thereof |
| 07/12/2007 | WO2006117596A3 Nucleic acid probes and nucleic acid analog probes |
| 07/12/2007 | WO2006113579A3 Tumor inhibition by modulating sprouty expression or activity |
| 07/12/2007 | WO2006110581A3 Cancer-related genes |
| 07/12/2007 | WO2006105415A3 Methods and compositions for in situ detection of microorganisms on a surface |
| 07/12/2007 | WO2006099329A3 Method of analyzing breast cancer susceptibility and resistance |
| 07/12/2007 | WO2006091964A3 Regulators of protein misfolding and aggregation and methods of using the same |
| 07/12/2007 | WO2006091795A3 METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS |
| 07/12/2007 | WO2006088623A3 Selection probe amplification |
| 07/12/2007 | WO2006055605A3 Method and substances for diagnosing bipolar disorder |
| 07/12/2007 | WO2006031928A3 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 07/12/2007 | WO2006026051A3 Selections of genes and methods of using the same for diagnosis, prognosis and for targeting the therapy of neuroblastoma |
| 07/12/2007 | WO2006002378A3 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 07/12/2007 | WO2005108971A3 Fast perfusion system and patch clamp technique utilizing an interface chamber system having high throughput and low volume requirements |
| 07/12/2007 | WO2005091823A3 The use of lunasin peptide as a transcriptional activator to prevent cancer and related methods for treatment, monitoring and prognosis |
| 07/12/2007 | WO2005047463A3 Hcv replicons containing ns5b from genotype 2b |
| 07/12/2007 | WO2005037232A3 Methods and compositions for modulating adipocyte function |
| 07/12/2007 | WO2005027962A3 4’-thionucleosides and oligomeric compounds |
| 07/12/2007 | WO2005019409A3 Combinatorial protein library screening by periplasmic expression |
| 07/12/2007 | WO2005012487A3 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 07/12/2007 | WO2004039990A3 Cells for determining the presence of a molecule that activates signal transduction activity of a cell surface protein |
| 07/12/2007 | US20070163000 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP. |
| 07/12/2007 | US20070162998 CeCPI: taro cysteine protease inhibitor |
| 07/12/2007 | US20070162997 Genetic markers linked to fusarium head blight-resistance factor and utilization thereof |
| 07/12/2007 | US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 07/12/2007 | US20070162993 Geranylgeranyl pyrophosphate synthases |
| 07/12/2007 | US20070162989 Methods and compositions for treating motor neuron associated disorders |
| 07/12/2007 | US20070162986 Anf analogue |
| 07/12/2007 | US20070162984 STARS-a muscle-specific actin-binding protein |
| 07/12/2007 | US20070162983 Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases |
| 07/12/2007 | US20070161636 Binding target to photoactive compound then irradiating with xenon arc lamp |
| 07/12/2007 | US20070161595 downregulation of the alpha-synuclein gene for the treatment of synucleinopathies; iRNA agents |
| 07/12/2007 | US20070161590 Methods and sequences to preferentially suppress expression of mutated huntingtin |
| 07/12/2007 | US20070161589 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents |
| 07/12/2007 | US20070161586 Drug for preventing and treating atherosclerosis |
| 07/12/2007 | US20070161565 Signal transduction protein TAB2 |
| 07/12/2007 | US20070161562 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 07/12/2007 | US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161548 diagnosing a pregnant woman at increased risk of preeclampsia; HELLP (hemolysis, elevated liver enzymes; contacting the sample with an antibody that specifically binds a marker |
| 07/12/2007 | US20070161542 Ptb1b photoprobes |
| 07/12/2007 | US20070161108 Bob-1 specific T cells and methods to use |
| 07/12/2007 | US20070161099 Methods for using polypeptides having amylase activity and nucleic acids encoding them |
| 07/12/2007 | US20070161085 Methods of Producing Influenza Vaccine Compositions |
| 07/12/2007 | US20070161078 Contacting a sample from the subject with a PDZ polypeptides (PDZ) and/or PDZ ligands (PL) and determining whether binding interactions occur between PDZ and PL |
| 07/12/2007 | US20070161076 Methods and systems for sampling, screening, and diagnosis |
| 07/12/2007 | US20070161075 Fluorescence microscope arrangement |
| 07/12/2007 | US20070161074 Diagnostic method of mucopolysaccharidoses |
| 07/12/2007 | US20070161073 Methods and products related to evaluating the quality of a polysaccharide |
| 07/12/2007 | US20070161072 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity |
| 07/12/2007 | US20070161071 Assay methods and systems |
| 07/12/2007 | US20070161070 Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times |
| 07/12/2007 | US20070161069 comprising a substrate with a coating system in which a Ruthenium complex and an enzyme is integrated; used in monitoring biotechnological processes based on fibre-optic systems; for synthesis of biofuels |
| 07/12/2007 | US20070161068 Method, reagent and kit for determination of cholesterol in very low-density lipoprotein remnant (vldl remnant) |
| 07/12/2007 | US20070161067 Split protein self complementing fragments, systems, and methods of use thereof |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070161058 Methods and compositions for diagnosing hepatocellular carcinoma |
| 07/12/2007 | US20070161057 Methods, compositions, and kits for detecting cyrptosporidium pathogens |
| 07/12/2007 | US20070161054 Methods and compositions for targeting secretory lysosomes |